Literature DB >> 10976413

The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.

A H Watt1, A T Legedza, E S Ginsburg, R L Barbieri, R N Clarke, M D Hornstein.   

Abstract

PURPOSE: Basal follicle-stimulating hormone (FSH) and age are predictors of successful outcome in in vitro fertilization (IVF). More recently, the clomiphene citrate challenge test (CCCT) has been proposed as a better way to predict IVF outcome than FSH alone. The purpose of this study was to determine which indicator of ovarian reserve--basal (day 3) FSH or the CCCT--is the better predictor of IVF success in the critical age group of women over the age of 40.
METHODS: In this retrospective study, basal FSH and clomiphene-stimulated FSH levels from 104 women who underwent 175 cycles of IVF were analyzed.
RESULTS: Neither basal FSH level nor stimulated FSH level alone were statistically significant predictors of IVF success; however, no patient with a day 3 FSH level > 11.1 mIU/ml or a stimulated day 10 FSH level > 13.5 mIU/ml conceived and carried a pregnancy. All ongoing pregnancies occurred in the first two cycles of IVF.
CONCLUSIONS: Clear prognostic cutoff values were found to predict IVF success in women over age 40. IVF programs should consider limiting the number of cycles of IVF in women above age 40.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976413      PMCID: PMC3455199          DOI: 10.1023/a:1009458332567

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  13 in total

1.  Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.

Authors:  J P Toner; C B Philput; G S Jones; S J Muasher
Journal:  Fertil Steril       Date:  1991-04       Impact factor: 7.329

2.  Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test.

Authors:  E Loumaye; J M Billion; J M Mine; I Psalti; M Pensis; K Thomas
Journal:  Fertil Steril       Date:  1990-02       Impact factor: 7.329

3.  Efficacy of selection criteria for ovarian reserve screening using the clomiphene citrate challenge test in a tertiary fertility center population.

Authors:  G E Hofmann; J Sosnowski; R T Scott; J Thie
Journal:  Fertil Steril       Date:  1996-07       Impact factor: 7.329

Review 4.  Reproductive potential in the older woman.

Authors:  P R Gindoff; R Jewelewicz
Journal:  Fertil Steril       Date:  1986-12       Impact factor: 7.329

5.  Prognostic assessment of female fecundity.

Authors:  D Navot; Z Rosenwaks; E J Margalioth
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

6.  Interinstitutional variability of follicle-stimulating hormone and estradiol levels.

Authors:  A Hershlag; M Lesser; D Montefusco; G Lavy; P Kaplan; H C Liu; D Rosenfeld
Journal:  Fertil Steril       Date:  1992-12       Impact factor: 7.329

7.  Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age.

Authors:  A C Pearlstone; N Fournet; J C Gambone; S C Pang; R P Buyalos
Journal:  Fertil Steril       Date:  1992-10       Impact factor: 7.329

8.  Effect of maternal age and number of in vitro fertilization procedures on pregnancy outcome.

Authors:  S L Padilla; J E Garcia
Journal:  Fertil Steril       Date:  1989-08       Impact factor: 7.329

9.  In-vitro fertilization: influence of women's age on pregnancy rates.

Authors:  C Piette; J de Mouzon; A Bachelot; A Spira
Journal:  Hum Reprod       Date:  1990-01       Impact factor: 6.918

Review 10.  Reproduction in the older gravida. A literature review.

Authors:  W W Newcomb; M Rodriguez; J W Johnson
Journal:  J Reprod Med       Date:  1991-12       Impact factor: 0.142

View more
  8 in total

Review 1.  Ovarian reserve evaluation: state of the art.

Authors:  Bruno Ramalho de Carvalho; Ana Carolina Japur de Sá Rosa e Silva; Júlio César Rosa e Silva; Rosana Maria dos Reis; Rui Alberto Ferriani; Marcos Felipe Silva de Sá
Journal:  J Assist Reprod Genet       Date:  2008-08-05       Impact factor: 3.412

2.  Too old for IVF: are we discriminating against older women?

Authors:  Norbert Gleicher; Andrea Weghofer; David Barad
Journal:  J Assist Reprod Genet       Date:  2007-12-04       Impact factor: 3.412

3.  Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus.

Authors:  Wei-Lin Ke; Wei-Hua Zhao; Xin-Yu Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.

Authors:  Ming-fang Miao; He-feng Huang
Journal:  J Zhejiang Univ Sci B       Date:  2009-01       Impact factor: 3.066

5.  Ovarian reserve assessment for infertility investigation.

Authors:  Bruno Ramalho de Carvalho; David Barreira Gomes Sobrinho; Andréa Duarte Damasceno Vieira; Manoela Porto Silva Resende; Antônio César Paes Barbosa; Adelino Amaral Silva; Hitomi Miura Nakagava
Journal:  ISRN Obstet Gynecol       Date:  2012-01-26

6.  Maximum basal FSH predicts reproductive outcome better than cycle-specific basal FSH levels: waiting for a "better" month conveys limited retrieval benefits.

Authors:  Julian A Gingold; Joseph A Lee; Michael C Whitehouse; Jorge Rodriguez-Purata; Benjamin Sandler; Lawrence Grunfeld; Tanmoy Mukherjee; Alan B Copperman
Journal:  Reprod Biol Endocrinol       Date:  2015-08-15       Impact factor: 5.211

7.  Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome.

Authors:  Sudha Prasad; Teena Gupta; Aabha Divya
Journal:  J Reprod Infertil       Date:  2013-01

8.  Defining human embryo phenotypes by cohort-specific prognostic factors.

Authors:  Sunny H Jun; Bokyung Choi; Lora Shahine; Lynn M Westphal; Barry Behr; Renee A Reijo Pera; Wing H Wong; Mylene W M Yao
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.